NEUROPHET, Inc. is an advanced neuroscience company located in Seoul, South Korea. As a leading provider of neuro-navigation technology, NEUROPHET enables clinicians to treat patients more precisely. We strive to make the world healthier by overcoming limitation of brain diseases. We will continue to innovate ourselves and lead the healthcare’s future. With unique expertise in the neuroscience field, Neurophet strives to improve the life of patients suffering from the neurological disorders by providing dianostic and treatment solutions that are relevant and essential for the healthcare providers. Neurophet produces solutions based on Segengine, the company’s own technology that automatically segments brain magnetic resonance (MR) images into 107 regions within a minute.
Total Funding: $5.1 M
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2016
